Emerging Strategies for Biomaterials-Mediated Reprogramming of Macrophages in Tissue Repair and Regeneration

Adult tissue repair is often limited, resulting in fibrotic scar formation rather than functional regeneration. Macrophages are central regulators of this process, driving inflammation, tissue formation, and remodeling. Increasing evidence demonstrates that macrophages exhibit substantial heterogeneity and plasticity, transitioning along a continuum of phenotypes in response to evolving microenvironmental cues rather than existing as discrete M1/M2 subsets. This functional diversity reflects their critical role across all stages of tissue repair, from early inflammatory responses to later regenerative and remodeling phases. Recent advances in bioengineering have enabled the development of biomaterial-based strategies to reprogram macrophages and enhance tissue repair. These include the controlled delivery of immunomodulatory biochemical signals, such as cytokines, proteins, and metabolites; the engineering of matrix biophysical properties, including stiffness, viscoelasticity, and topography; and the enhancement of efferocytosis to promote inflammation resolution and tissue homeostasis. These approaches demonstrate that macrophage behavior can be modulated through both biochemical and physical cues to improve regenerative outcomes across diverse tissue contexts. This review summarises current understanding of macrophage heterogeneity and plasticity during tissue repair and highlights emerging biomaterials-driven strategies for macrophage reprogramming, providing a framework for leveraging macrophage function to support effective tissue regeneration.

Authors

Institutions

Publication Details

Journal
Regenerative medicine and dentistry.
Published
2026-07-24
DOI
https://doi.org/10.53941/rmd.2026.100011
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emerging Strategies for Biomaterials-Mediated Reprogramming of Macrophages in Tissue Repair and Regeneration

Anthony S. Weiss, Juejie Chen, Linyang Liu, Ziyu Wang et al.
Regenerative medicine and dentistry.
Immune cells in cancer
article

Emerging Strategies for Biomaterials-Mediated Reprogramming of Macrophages in Tissue Repair and Regeneration

Anthony S. Weiss, Juejie Chen, Linyang Liu, Ziyu Wang, Jeeyoon Park, Miao Zhang
article en

Abstract

Adult tissue repair is often limited, resulting in fibrotic scar formation rather than functional regeneration. Macrophages are central regulators of this process, driving inflammation, tissue formation, and remodeling. Increasing evidence demonstrates that macrophages exhibit substantial heterogeneity and plasticity, transitioning along a continuum of phenotypes in response to evolving microenvironmental cues rather than existing as discrete M1/M2 subsets. This functional diversity reflects their critical role across all stages of tissue repair, from early inflammatory responses to later regenerative and remodeling phases. Recent advances in bioengineering have enabled the development of biomaterial-based strategies to reprogram macrophages and enhance tissue repair. These include the controlled delivery of immunomodulatory biochemical signals, such as cytokines, proteins, and metabolites; the engineering of matrix biophysical properties, including stiffness, viscoelasticity, and topography; and the enhancement of efferocytosis to promote inflammation resolution and tissue homeostasis. These approaches demonstrate that macrophage behavior can be modulated through both biochemical and physical cues to improve regenerative outcomes across diverse tissue contexts. This review summarises current understanding of macrophage heterogeneity and plasticity during tissue repair and highlights emerging biomaterials-driven strategies for macrophage reprogramming, providing a framework for leveraging macrophage function to support effective tissue regeneration.

Regenerative medicine and dentistry.Vol. 3(3)
The University of Sydney (AU), Nepean Hospital (AU), Cooperative Trials Group for Neuro-Oncology (AU), Baird Institute (AU)
University of Sydney, National Health and Medical Research Council
Openalex Percentile: Top 14%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.